Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Cardiac Registry Software Market: By Types of Registry By Type of Software By Pricing Model By Deployment Model By Type of Database By Functionality By End User and Geography
The Cardiac Registry Software Market size is valued at US$ 465.8 million in 2022 and is expected to grow at a significant CAGR of 8.8% during the forecast period from 2023 to 2029. The global market provides a detailed overview of the market and that can be segmented By types of registry, type of software, pricing model, deployment model, type of database, functionality, end user. By Types of Registry, the cardiac registry software market has been segmented into disease registry, health service registries, product registries, medical device registries, drug registries. The Disease Registry segment is likely to be the largest and fastest-growing segment in terms of types of registry. Based on type of software, the Cardiac Registry Software market is segmented into Standalone Software, Integrated Software. Among these, the Standalone Software segment is expected to have the fastest-growing market during the forecast period 2023-2029. Based on the pricing model, the cardiac registry software market is segmented into Subscription Model, Ownership Model. Subscription Model are expected to dominate the market in the future. Based on deployment model, the market has been segmented into On-premises Model, Cloud-Based Model. On-premises Model segment expected to grow at the highest CAGR over the forecast years. Based on the type of database, the market has been segregated into Commercial Database, Public Database.
The Commercial Database segment is to dominate other segments in the Cardiac Registry Software market. Based on the functionality, the market has been segregated into Population Health Management, Patient Care Management, Medical Research & Clinical Studies, Health Information Exchange, Point-of-Care, Product Outcome Evaluation. The Population Health Management segment is to dominate other segments in the Cardiac Registry Software market according to Precision Business Insights. Based on the type of end user, the market has been segregated into Government Organizations and Third-Party Administrators, Hospitals & Medical Practice, Private Payers, Pharmaceutical, Biotechnology, and Medical Device Companies, Research Centers. The Government Organizations and Third-Party Administrators segment is to dominate other segments in the Cardiac Registry Software market according to Precision Business Insights.
Study Period
2024-2030Base Year
2023CAGR
8.8%Largest Market
Asia-PacificFastest Growing Market
North America
The transition toward computerised registries which give users with an automated mechanism to save data and compile, organise, and display patient lists for use in planning, quality improvement, reporting, and direct care delivery, is primarily responsible for the market's rise.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2022 |
US$ 465.8 million |
Market CAGR |
8.8% |
By Type |
|
Type of Software |
|
By End User |
|
Download Free Sample Report
The cardiac registry software market is projected to expand at a CAGR of 8.8% during the forecast period.
The major players in the global Cardiac Registry Software market are IBM Corporation, IQVIA Holdings, OpenText Corporation, Optum, ARMUS Corporation, Premier, Inc., ArborMetrix, FIGmd, McKesson Corporation, Syneos Health, Dacima Software.
North America is the fastest-growing region for cardiac registry software market
1. Executive Summary |
2. Global Cardiac Registry Software Market Introduction |
2.1. Global Cardiac Registry Software Market - Taxonomy |
2.2. Global Cardiac Registry Software Market -Definitions |
2.2.1. By Types of Registry |
2.2.2. By Type of Software |
2.2.3. By Pricing Model |
2.2.4. By Deployment Model |
2.2.5. By Type of Database |
2.2.6. By Functionality |
2.2.7. By End User |
2.2.8. By Region |
3. Global Cardiac Registry Software Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Cardiac Registry Software Market Dynamic Factors - Impact Analysis |
3.6. Global Cardiac Registry Software Market - Competition Landscape |
4. Global Cardiac Registry Software Market Analysis, 2018-2022 and Forecast, 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Cardiac Registry Software Market, By Types of Registry, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.1. Disease Registry |
5.1.1. Heart Arrhythmia |
5.1.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.3. Market Opportunity Analysis |
5.1.2. Heart Valve Disease |
5.1.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.2.3. Market Opportunity Analysis |
5.1.3. Heart Failure |
5.1.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3.3. Market Opportunity Analysis |
5.1.4. Coronary Artery Disease |
5.1.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.4.3. Market Opportunity Analysis |
5.1.5. Others |
5.1.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.1.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.5.3. Market Opportunity Analysis |
5.2. Health Service Registries |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Product Registries |
5.3.1. Medical Device Registries |
5.3.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.1.3. Market Opportunity Analysis |
5.3.2. Drug Registries |
5.3.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.2.3. Market Opportunity Analysis |
6. Global Cardiac Registry Software Market, By Type of Software, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.1. Standalone Software |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Integrated Software |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Cardiac Registry Software Market, By Pricing Model, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.1. Â Subscription Model |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Â Ownership Model |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8. Global Cardiac Registry Software Market Forecast, By Deployment Model, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
8.1. On-premises Model |
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Cloud Based Model |
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
9. Global Cardiac Registry Software Market Forecast, By Type of Database, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.1. Commercial Database |
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Public Database |
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
10. Global Cardiac Registry Software Market Forecast, By Functionality, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
10.1. Population Health Management |
10.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.1.3. Market Opportunity Analysis |
10.2. Patient Care Management |
10.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.2.3. Market Opportunity Analysis |
10.3. Â Medical Research & Clinical Studies |
10.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.3.3. Market Opportunity Analysis |
10.4. Â Health Information Exchange |
10.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.4.3. Market Opportunity Analysis |
10.5. Â Point-of-Care |
10.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.5.3. Market Opportunity Analysis |
10.6. Â Product Outcome Evaluation |
10.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
10.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.6.3. Market Opportunity Analysis |
11. Global Cardiac Registry Software Market Forecast, By End User, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
11.1. Government Organizations and Third-Party Administrators |
11.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
11.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
11.1.3. Market Opportunity Analysis |
11.2. Hospitals & Medical Practices |
11.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
11.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
11.2.3. Market Opportunity Analysis |
11.3. Â Private Payers |
11.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
11.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
11.3.3. Market Opportunity Analysis |
11.4. Â Pharmaceutical, Biotechnology, and Medical Device Companies |
11.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
11.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
11.4.3. Market Opportunity Analysis |
11.5. Research Centers |
11.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
11.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
11.5.3. Market Opportunity Analysis |
12. Global Cardiac Registry Software Market Forecast, By Region, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
12.1. North America |
12.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
12.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
12.1.3. Market Opportunity Analysis |
12.2. Europe |
12.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
12.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
12.2.3. Market Opportunity Analysis |
12.3. Asia-Pacific |
12.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
12.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
12.3.3. Market Opportunity Analysis |
12.4. Latin America |
12.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
12.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
12.4.3. Market Opportunity Analysis |
12.5. Middle East and Africa |
12.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
12.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
12.5.3. Market Opportunity Analysis |
12.6. Global Cardiac Registry Software Market - Opportunity Analysis Index, By Types of Registry, By Type of Software, By Pricing Model, By Deployment Model, By Type of Database, By Functionality, By End User, and Region, 2022-2028 |
13. North America Cardiac Registry Software Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
13.1. Types of Registry Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Disease Registry |
13.1.1.1. Heart Arrhythmia |
13.1.1.2. Heart Valve Disease |
13.1.1.3. Coronary Artery Disease |
13.1.1.4. Heart Failure |
13.1.1.5. Others |
13.1.2. Health Service Registries |
13.1.3. Product Registries |
13.1.3.1. Medical Device Registries |
13.1.3.2. Drug Registries |
13.2. Type of Software Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Standalone Software |
13.2.2. Integrated Software |
13.3. Pricing Model Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Subscription Model |
13.3.2. Ownership Model |
13.4. Deployment Model Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. On-premises Model |
13.4.2. Cloud-Based Model |
13.5. Type of Database Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Commercial Database |
13.5.2. Public Database |
13.6. Functionality Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.6.1. Population Health Management |
13.6.2. Patient Care Management |
13.6.3. Medical Research & Clinical Studies |
13.6.4. Health Information Exchange |
13.6.5. Point-of-Care |
13.6.6. Product Outcome Evaluation |
13.7. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.7.1. Government Organizations and Third-Party Administrators |
13.7.2. Hospitals & Medical Practices |
13.7.3. Private Payers |
13.7.4. Pharmaceutical, Biotechnology, and Medical Device Companies |
13.7.5. Research Centers |
13.8. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.8.1. USA |
13.8.2. Canada |
13.9. North America Cardiac Registry Software Market - Opportunity Analysis Index, By Types of Registry, By Type of Software, By Pricing Model, By Deployment Model, By Type of Database, By Functionality, By End User, and Country, 2022-2028 |
13.10. North America Cardiac Registry Software Market Dynamics - Trends |
14. Europe Cardiac Registry Software Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
14.1. Types of Registry Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Disease Registry |
14.1.1.1. Heart Arrhythmia |
14.1.1.2. Heart Valve Disease |
14.1.1.3. Coronary Artery Disease |
14.1.1.4. Heart Failure |
14.1.1.5. Others |
14.1.2. Health Service Registries |
14.1.3. Product Registries |
14.1.3.1. Medical Device Registries |
14.1.3.2. Drug Registries |
14.2. Type of Software Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
14.2.1. Standalone Software |
14.2.2. Integrated Software |
14.3. Pricing Model Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Subscription Model |
14.3.2. Ownership Model |
14.4. Deployment Model Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. On-premises Model |
14.4.2. Cloud-Based Model |
14.5. Type of Database Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Commercial Database |
14.5.2. Public Database |
14.6. Functionality Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.6.1. Population Health Management |
14.6.2. Patient Care Management |
14.6.3. Medical Research & Clinical Studies |
14.6.4. Health Information Exchange |
14.6.5. Point-of-Care |
14.6.6. Product Outcome Evaluation |
14.7. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.7.1. Government Organizations and Third-Party Administrators |
14.7.2. Hospitals & Medical Practices |
14.7.3. Private Payers |
14.7.4. Pharmaceutical, Biotechnology, and Medical Device Companies |
14.7.5. Research Centers |
14.8. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.8.1. Germany |
14.8.2. UK |
14.8.3. France |
14.8.4. Spain |
14.8.5. Italy |
14.8.6. Russia |
14.8.7. Rest of Europe |
14.9. Europe Cardiac Registry Software Market - Opportunity Analysis Index, By Types of Registry, By Type of Software, By Pricing Model, By Deployment Model, By Type of Database, By Functionality, By End User, and Country, 2022-2028 |
14.10. Europe Cardiac Registry Software Market Dynamics - Trends |
15. Asia-Pacific Cardiac Registry Software Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
15.1. Types of Registry Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
15.1.1. Â Disease Registry |
15.1.1.1. Heart Arrhythmia |
15.1.1.2. Heart Valve Disease |
15.1.1.3. Coronary Artery Disease |
15.1.1.4. Heart Failure |
15.1.1.5. Others |
15.1.2. Health Service Registries |
15.1.3. Product Registries |
15.1.3.1. Medical Device Registries |
15.1.3.2. Drug Registries |
15.2. Type of Software Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
15.2.1. Standalone Software |
15.2.2. Integrated Software |
15.3. Pricing Model Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.3.1. Subscription Model |
15.3.2. Ownership Model |
15.4. Deployment Model Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.4.1. On-premises Model |
15.4.2. Cloud-Based Model |
15.5. Type of Database Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.5.1. Commercial Database |
15.5.2. Public Database |
15.6. Functionality Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.6.1. Population Health Management |
15.6.2. Patient Care Management |
15.6.3. Medical Research & Clinical Studies |
15.6.4. Health Information Exchange |
15.6.5. Point-of-Care |
15.6.6. Product Outcome Evaluation |
15.7. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.7.1. Government Organizations and Third-Party Administrators |
15.7.2. Hospitals & Medical Practices |
15.7.3. Private Payers |
15.7.4. Pharmaceutical, Biotechnology, and Medical Device Companies |
15.7.5. Research Centers |
15.8. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
15.8.1. China |
15.8.2. India |
15.8.3. Japan |
15.8.4. ASEAN |
15.8.5. Australia & New Zealand |
15.8.6. Rest of Asia-Pacific |
15.9. Asia-Pacific Cardiac Registry Software Market - Opportunity Analysis Index, By Types of Registry, By Type of Software, By Pricing Model, By Deployment Model, By Type of Database, By Functionality, By End User, and Country, 2022-2028 |
15.10. Asia-Pacific Cardiac Registry Software Market Dynamics - Trends |
16. Latin America Cardiac Registry Software Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
16.1. Types of Registry Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
16.1.1. Â Disease Registry |
16.1.1.1. Heart Arrhythmia |
16.1.1.2. Heart Valve Disease |
16.1.1.3. Coronary Artery Disease |
16.1.1.4. Heart Failure |
16.1.1.5. Others |
16.1.2. Health Service Registries |
16.1.3. Product Registries |
16.1.3.1. Medical Device Registries |
16.1.3.2. Drug Registries |
16.2. Type of Software Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
16.2.1. Standalone Software |
16.2.2. Integrated Software |
16.3. Pricing Model Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
16.3.1. Subscription Model |
16.3.2. Ownership Model |
16.4. Deployment Model Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
16.4.1. On-premises Model |
16.4.2. Cloud-Based Model |
16.5. Type of Database Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
16.5.1. Commercial Database |
16.5.2. Public Database |
16.6. Functionality Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
16.6.1. Population Health Management |
16.6.2. Patient Care Management |
16.6.3. Medical Research & Clinical Studies |
16.6.4. Health Information Exchange |
16.6.5. Point-of-Care |
16.6.6. Product Outcome Evaluation |
16.7. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
16.7.1. Government Organizations and Third-Party Administrators |
16.7.2. Hospitals & Medical Practices |
16.7.3. Private Payers |
16.7.4. Pharmaceutical, Biotechnology, and Medical Device Companies |
16.7.5. Research Centers |
16.8. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
16.8.1. Brazil |
16.8.2. Mexico |
16.8.3. Rest of Latin America |
16.9. Latin America Cardiac Registry Software Market - Opportunity Analysis Index, By Types of Registry, By Type of Software, By Pricing Model, By Deployment Model, By Type of Database, By Functionality, By End User, and Country, 2022-2028 |
16.10. Latin America Cardiac Registry Software Market Dynamics - Trends |
17. Middle East and Africa Cardiac Registry Software Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, USD Mn) |
17.1. Types of Registry Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
17.1.1. Â Disease Registry |
17.1.1.1. Heart Arrhythmia |
17.1.1.2. Heart Valve Disease |
17.1.1.3. Coronary Artery Disease |
17.1.1.4. Heart Failure |
17.1.1.5. Others |
17.1.2. Health Service Registries |
17.1.3. Product Registries |
17.1.3.1. Medical Device Registries |
17.1.3.2. Drug Registries |
17.2. Type of Software Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
17.2.1. Standalone Software |
17.2.2. Integrated Software |
17.3. Pricing Model Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
17.3.1. Subscription Model |
17.3.2. Ownership Model |
17.4. Deployment Model Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
17.4.1. On-premises Model |
17.4.2. Cloud-Based Model |
17.5. Type of Database Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
17.5.1. Commercial Database |
17.5.2. Public Database |
17.6. Functionality Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
17.6.1. Population Health Management |
17.6.2. Patient Care Management |
17.6.3. Medical Research & Clinical Studies |
17.6.4. Health Information Exchange |
17.6.5. Point-of-Care |
17.6.6. Product Outcome Evaluation |
17.7. End User Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
17.7.1. Government Organizations and Third-Party Administrators |
17.7.2. Hospitals & Medical Practices |
17.7.3. Private Payers |
17.7.4. Pharmaceutical, Biotechnology, and Medical Device Companies |
17.7.5. Research Centers |
17.8. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
17.8.1. Gulf Cooperation Council (GCC) Countries |
17.8.2. South Africa |
17.8.3. Rest of MEA |
17.9. MEA Cardiac Registry Software Market - Opportunity Analysis Index, By Types of Registry, By Type of Software, By Pricing Model, By Deployment Model, By Type of Database, By Functionality, By End User, and Country, 2022-2028 |
17.10. MEA Cardiac Registry Software Market Dynamics - Trends |
18. Competition Landscape |
18.1. Strategic Dashboard of Top Market Players |
18.2. Company Profiles (Introduction, Financial Analysis, Key Product, Key Developments, Strategies, and SWOT Analysis) |
18.2.1. IBM Corporation |
18.2.2. IQVIA Holdings |
18.2.3. OpenText Corporation |
18.2.4. Optum |
18.2.5. ARMUS Corporation |
18.2.6. Premier, Inc. |
18.2.7. ArborMetrix |
18.2.8. FIGmd |
18.2.9. McKesson Corporation |
18.2.10. Syneos Health |
18.2.11. Dacima Software |
19. Research Methodology |
20. Key Assumptions and Acronyms |
Key Market Players